Lang James Paul — SEC Form 4 filings
SEC reporting owner CIK 1703090. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-11 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 321,408 shares, $2,443,761 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 321,408 shares @ $7.60 ($2,443,761) in OptimizeRx Corp, filed 2025-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| OptimizeRx Corp (OPRX) | Director | 4 | 1 leg · 321,408 sh · $2,443,761 | — | 5 |
| BIOVIE INC. (BIVI) | Director | 2 | — | — | 4 |
| HALOZYME THERAPEUTICS, INC. (HALO) | Director | 2 | — | — | 4 |
Form 4 filings — Lang James Paul
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 34,517 @ $0 | EDGAR |
| 2026-05-07 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 3,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | BIOVIE INC. (BIVI) | Grant/award (A): 90,000 (derivative) @ $0 · Grant/award (A): 330,500 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 889 @ $0 · Grant/award (A): 1,342 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | OptimizeRx Corp (OPRX) | Grant/award (A): 9,868 @ $0 | EDGAR |
| 2025-03-19 | 4 | OptimizeRx Corp (OPRX) | Purchase (P): 321,408 @ $7.60 | EDGAR |
| 2025-01-07 | 4 | BIOVIE INC. (BIVI) | Grant/award (A): 61,600 (derivative) @ $0 · Grant/award (A): 22,690 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | OptimizeRx Corp (OPRX) | Option exercise (M): 10,061 @ $0 · Grant/award (A): 13,286 @ $0 · Option exercise (M): 10,061 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1703090 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →